|
US9217155B2
(en)
|
2008-05-28 |
2015-12-22 |
University Of Massachusetts |
Isolation of novel AAV'S and uses thereof
|
|
SG10202109219SA
(en)
|
2009-05-02 |
2021-10-28 |
Genzyme Corp |
Gene therapy for neurodegenerative disorders
|
|
WO2010138263A2
(en)
|
2009-05-28 |
2010-12-02 |
University Of Massachusetts |
Novel aav 's and uses thereof
|
|
EP2561075B1
(en)
|
2010-04-23 |
2018-06-27 |
University of Massachusetts |
Aav-based treatment of cholesterol-related disorders
|
|
CA2833905C
(en)
|
2010-04-23 |
2019-09-10 |
University Of Massachusetts |
Multicistronic expression constructs
|
|
DK2826860T3
(en)
|
2010-04-23 |
2018-12-03 |
Univ Massachusetts |
CNS targeting AAV vectors and methods for their use
|
|
US8663624B2
(en)
|
2010-10-06 |
2014-03-04 |
The Regents Of The University Of California |
Adeno-associated virus virions with variant capsid and methods of use thereof
|
|
EP3318634A1
(en)
|
2011-04-21 |
2018-05-09 |
University of Massachusetts |
Raav-based compositions and methods for treating diseases involving dominant-negative or gain of function mutations
|
|
DK4005603T3
(da)
|
2011-04-22 |
2024-11-25 |
Univ California |
Adeno-associerede virus-virioner med variant kapsid og fremgangsmåder til anvendelse heraf
|
|
CA2912678C
(en)
|
2013-05-15 |
2023-10-10 |
Regents Of The University Of Minnesota |
Adeno-associated virus mediated gene transfer to the central nervous system
|
|
CA2907799A1
(en)
|
2013-05-31 |
2014-12-04 |
The Regents Of The University Of California |
Adeno-associated virus variants and methods of use thereof
|
|
US9585971B2
(en)
|
2013-09-13 |
2017-03-07 |
California Institute Of Technology |
Recombinant AAV capsid protein
|
|
US10072251B2
(en)
|
2014-02-19 |
2018-09-11 |
University Of Massachusetts |
Recombinant AAVS having useful transcytosis properties
|
|
ES3042252T3
(en)
|
2014-03-17 |
2025-11-19 |
Adverum Biotechnologies Inc |
Compositions and methods for enhanced gene expression in cone cells
|
|
AU2015231294B2
(en)
|
2014-03-18 |
2020-10-29 |
University Of Massachusetts |
rAAV-based compositions and methods for treating amyotrophic lateral sclerosis
|
|
WO2015164786A1
(en)
|
2014-04-25 |
2015-10-29 |
University Of Massachusetts |
Recombinant aav vectors useful for reducing immunity against transgene products
|
|
WO2015168666A2
(en)
|
2014-05-02 |
2015-11-05 |
Genzyme Corporation |
Aav vectors for retinal and cns gene therapy
|
|
KR102446169B1
(ko)
*
|
2014-05-14 |
2022-09-22 |
에스테베 파마슈티칼스 에스에이 |
리소좀 저장 장애의 치료를 위한 아데노연관 바이러스 벡터
|
|
WO2015187825A2
(en)
|
2014-06-03 |
2015-12-10 |
University Of Massachusetts |
Compositions and methods for modulating dysferlin expression
|
|
EP3795580A1
(en)
|
2014-10-03 |
2021-03-24 |
University of Massachusetts |
High efficiency library-identified aav vectors
|
|
WO2016054554A1
(en)
|
2014-10-03 |
2016-04-07 |
University Of Massachusetts |
Heterologous targeting peptide grafted aavs
|
|
WO2016065001A1
(en)
|
2014-10-21 |
2016-04-28 |
University Of Massachusetts |
Recombinant aav variants and uses thereof
|
|
NZ772772A
(en)
|
2015-02-10 |
2024-12-20 |
Genzyme Corp |
Enhanced delivery of viral particles to the striatum and cortex
|
|
SG11201706444TA
(en)
|
2015-02-10 |
2017-09-28 |
Genzyme Corp |
VARIANT RNAi
|
|
US10584321B2
(en)
|
2015-02-13 |
2020-03-10 |
University Of Massachusetts |
Compositions and methods for transient delivery of nucleases
|
|
CN114480502A
(zh)
|
2015-03-02 |
2022-05-13 |
阿德夫拉姆生物技术股份有限公司 |
用于将多核苷酸玻璃体内递送到视网膜视锥的组合物和方法
|
|
US10646588B2
(en)
*
|
2015-03-11 |
2020-05-12 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
RP2 and RPGR vectors for treating X-linked retinitis pigmentosa
|
|
WO2016154344A1
(en)
|
2015-03-24 |
2016-09-29 |
The Regents Of The University Of California |
Adeno-associated virus variants and methods of use thereof
|
|
PH12017501834B1
(en)
|
2015-04-06 |
2024-01-17 |
Arcellx Inc |
De novo binding domain containing polypeptides and uses thereof
|
|
ES2755725T3
(es)
|
2015-04-08 |
2020-04-23 |
Us Health |
Terapia génica viral como tratamiento para una enfermedad o un trastorno por almacenamiento de colesterol
|
|
TWI707951B
(zh)
|
2015-04-08 |
2020-10-21 |
美商健臻公司 |
過大腺相關載體之製造
|
|
CA3021949C
(en)
|
2015-04-24 |
2023-10-17 |
University Of Massachusetts |
Modified aav constructs and uses thereof
|
|
GB201508025D0
(en)
|
2015-05-11 |
2015-06-24 |
Ucl Business Plc |
Fabry disease gene therapy
|
|
GB201508026D0
(en)
|
2015-05-11 |
2015-06-24 |
Ucl Business Plc |
Capsid
|
|
JP7064214B2
(ja)
|
2015-09-28 |
2022-05-10 |
ザ・ユニヴァーシティ・オヴ・ノース・キャロライナ・アト・チャペル・ヒル |
抗体回避性ウイルスベクターのための方法および組成物
|
|
WO2017070525A1
(en)
|
2015-10-22 |
2017-04-27 |
University Of Massachusetts |
Methods and compositions for treating metabolic imbalance in neurodegenerative disease
|
|
US11426469B2
(en)
|
2015-10-22 |
2022-08-30 |
University Of Massachusetts |
Prostate-targeting adeno-associated virus serotype vectors
|
|
WO2017075335A1
(en)
|
2015-10-28 |
2017-05-04 |
Voyager Therapeutics, Inc. |
Regulatable expression using adeno-associated virus (aav)
|
|
DK3387137T3
(da)
|
2015-12-11 |
2021-05-03 |
California Inst Of Techn |
Målretningspeptider til styring af adeno-associerede virusser (aav`er)
|
|
CA3008268A1
(en)
*
|
2015-12-15 |
2017-06-22 |
Genzyme Corporation |
Adeno-associated viral vectors for treating mucolipidosis type ii
|
|
EP3411059A4
(en)
*
|
2016-02-02 |
2019-10-16 |
University Of Massachusetts |
METHOD FOR INCREASING THE EFFECTIVENESS OF THE SYSTEMIC DELIVERY OF AVV GENES TO THE CENTRAL NERVOUS SYSTEM
|
|
EP3413928B1
(en)
|
2016-02-12 |
2022-04-20 |
University of Massachusetts |
Anti-angiogenic mirna therapeutics for inhibiting corneal neovascularization
|
|
WO2017147477A1
(en)
*
|
2016-02-26 |
2017-08-31 |
University Of Florida Research Foundation, Inc. |
Aav heparin mutants that display significantly improved eye and brain transduction
|
|
US11207426B2
(en)
|
2016-04-05 |
2021-12-28 |
University Of Massachusetts |
Compositions and methods for selective inhibition of grainyhead-like protein expression
|
|
CN107287238B
(zh)
*
|
2016-04-11 |
2020-10-16 |
厦门继景生物技术有限责任公司 |
一种基因载体及其用于治疗雷柏氏先天性黑矇2型疾病的基因治疗药物
|
|
WO2017181105A1
(en)
|
2016-04-15 |
2017-10-19 |
University Of Massachusetts |
Methods and compositions for treating metabolic imbalance
|
|
GB201608046D0
(en)
|
2016-05-09 |
2016-06-22 |
Cambridge Entpr Ltd And Syndey Children S Hospitals Network Randwick And Westmead Incorporating The |
Treatment of complement-mediated disorders
|
|
BR112018073472A2
(pt)
*
|
2016-05-18 |
2019-08-27 |
Voyager Therapeutics, Inc. |
composições e métodos de tratamento da doença de huntington
|
|
WO2017218852A1
(en)
|
2016-06-15 |
2017-12-21 |
University Of Massachusetts |
Recombinant adeno-associated viruses for delivering gene editing molecules to embryonic cells
|
|
KR102526506B1
(ko)
*
|
2016-07-08 |
2023-05-03 |
더 트러스티스 오브 더 유니버시티 오브 펜실베니아 |
Rdh12가 연루된 장애 및 질환의 치료를 위한 방법 및 조성물
|
|
WO2018011572A1
(en)
*
|
2016-07-12 |
2018-01-18 |
The University Of Manchester |
Gene therapy
|
|
CA3029833A1
(en)
|
2016-07-29 |
2018-02-01 |
The Regents Of The University Of California |
Adeno-associated virus virions with variant capsid and methods of use thereof
|
|
JP7226801B2
(ja)
*
|
2016-08-16 |
2023-02-21 |
ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル |
標的遺伝子導入のための方法および組成物
|
|
AU2017313917B2
(en)
*
|
2016-08-18 |
2023-12-21 |
The Regents Of The University Of California |
CRISPR-Cas genome engineering via a modular AAV delivery system
|
|
KR20230130155A
(ko)
|
2016-08-19 |
2023-09-11 |
유니버시티 오브 플로리다 리서치 파운데이션, 인코포레이티드 |
재조합 자기-상보적인 아데노-부속 바이러스를 이용한 병태의 치료 방법 및 조성물
|
|
WO2018035457A1
(en)
*
|
2016-08-19 |
2018-02-22 |
Calimmune, Inc. |
Methods and compositions for treating canine conditions using recombinant self-complementary adeno-associated virus
|
|
US10457940B2
(en)
|
2016-09-22 |
2019-10-29 |
University Of Massachusetts |
AAV treatment of Huntington's disease
|
|
WO2018064098A1
(en)
|
2016-09-28 |
2018-04-05 |
Cohbar, Inc. |
Therapeutic mots-c related peptides
|
|
EP3518985A4
(en)
|
2016-09-29 |
2020-08-05 |
University of Florida Research Foundation, Incorporated |
AAVRH.10 VARIANTS WITH HOST ANTIBODY EXHAUST CAPACITIES AND MODIFIED TISSUE TARGETING PROPERTIES
|
|
US11578340B2
(en)
|
2016-10-13 |
2023-02-14 |
University Of Massachusetts |
AAV capsid designs
|
|
AU2017345470B2
(en)
|
2016-10-19 |
2023-08-03 |
Adverum Biotechnologies, Inc. |
Modified AAV capsids and uses thereof
|
|
WO2018106956A2
(en)
|
2016-12-07 |
2018-06-14 |
University Of Florida Research Foundation, Incorporated |
IL-1RA CDNAs
|
|
WO2018145009A1
(en)
*
|
2017-02-06 |
2018-08-09 |
University Of Tennessee Research Foundation |
Dna-zyme based methods & compositions for treating huntington's disease
|
|
WO2018156892A1
(en)
|
2017-02-23 |
2018-08-30 |
Adrx, Inc. |
Peptide inhibitors of transcription factor aggregation
|
|
JOP20190200A1
(ar)
|
2017-02-28 |
2019-08-27 |
Univ Pennsylvania |
تركيبات نافعة في معالجة ضمور العضل النخاعي
|
|
WO2018191450A2
(en)
|
2017-04-14 |
2018-10-18 |
National Taiwan University Hospital |
Gene therapy for aadc deficiency
|
|
WO2018200419A1
(en)
*
|
2017-04-23 |
2018-11-01 |
The Trustees Of The University Of Pennsylvania |
Viral vectors comprising engineered aav capsids and compositions containing the same
|
|
CN111108198A
(zh)
|
2017-05-05 |
2020-05-05 |
沃雅戈治疗公司 |
治疗亨廷顿病的组合物和方法
|
|
EP3622073A4
(en)
|
2017-05-09 |
2021-01-06 |
University of Massachusetts |
METHOD FOR TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS)
|
|
CA3061968A1
(en)
|
2017-05-10 |
2018-11-15 |
Massachusetts Eye And Ear Infirmary |
Methods and compositions for modifying assembly-activating protein (aap)-dependence of viruses
|
|
EP3634978A1
(en)
|
2017-06-07 |
2020-04-15 |
Adrx, Inc. |
Tau aggregation inhibitors
|
|
BR112019019015A2
(pt)
*
|
2017-06-30 |
2020-04-14 |
Univ California |
vírions de vírus adeno-associado com capsídeos variantes e seus métodos de uso
|
|
WO2019028306A2
(en)
*
|
2017-08-03 |
2019-02-07 |
Voyager Therapeutics, Inc. |
COMPOSITIONS AND METHODS FOR ADMINISTRATION OF ADENO-ASSOCIATED VIRUSES
|
|
EP3676373A4
(en)
|
2017-08-28 |
2021-06-09 |
The Regents of The University of California |
Adeno-associated virus capsid variants and methods of use thereof
|
|
US20200377887A1
(en)
*
|
2017-09-22 |
2020-12-03 |
Voyager Therapeutics, Inc. |
Compositions and methods of treating huntington's disease
|
|
MY205041A
(en)
|
2017-09-22 |
2024-09-29 |
Genzyme Corp |
Variant rnai
|
|
JP7397488B2
(ja)
|
2017-09-22 |
2023-12-13 |
ユニバーシティ オブ マサチューセッツ |
Ｓｏｄ１二重発現ベクターおよびその使用
|
|
EP3697896A1
(en)
*
|
2017-10-16 |
2020-08-26 |
Vigeneron GmbH |
Aav vectors
|
|
US11723988B2
(en)
|
2017-10-20 |
2023-08-15 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods of expressing a polynucleotide of interest in the cone photoreceptors of a subject comprising the subretinal delivery of a therapeutically effective amount of a recombinant AAV9-derived vector
|
|
US11464803B2
(en)
|
2017-11-14 |
2022-10-11 |
Arcellx, Inc. |
D-domain containing polypeptides and uses thereof
|
|
CN111511383A
(zh)
|
2017-11-14 |
2020-08-07 |
阿奇利克斯股份有限公司 |
多功能免疫细胞疗法
|
|
CA3082080A1
(en)
*
|
2017-11-15 |
2019-05-23 |
Friedrich Miescher Institute For Biomedical Research |
Primate retinal pigment epithelium cell-specific promoter
|
|
WO2019099696A1
(en)
*
|
2017-11-15 |
2019-05-23 |
The Regents Of The University Of Michigan |
Viral vectors comprising rdh12 coding regions and methods of treating retinal dystrophies
|
|
EP3714055A1
(en)
|
2017-11-21 |
2020-09-30 |
CRISPR Therapeutics AG |
Materials and methods for treatment of autosomal dominant retinitis pigmentosa
|
|
CN108085316B
(zh)
*
|
2017-12-25 |
2021-02-09 |
中国人民解放军第四军医大学 |
一种通过抑制微小核糖核酸来促进小鼠视网膜前体细胞体外扩增的方法
|
|
JP2021519067A
(ja)
*
|
2018-03-23 |
2021-08-10 |
ザ・トラスティーズ・オブ・コロンビア・ユニバーシティ・イン・ザ・シティ・オブ・ニューヨーク |
常染色体優性疾患のための遺伝子編集
|
|
MX2020010464A
(es)
|
2018-04-03 |
2021-01-29 |
|
Vectores de virus que evitan anticuerpos.
|
|
JP7425738B2
(ja)
|
2018-04-03 |
2024-01-31 |
ギンコ バイオワークス インコーポレイテッド |
眼組織を標的とするウイルスベクター
|
|
US12091435B2
(en)
|
2018-04-03 |
2024-09-17 |
Ginkgo Bioworks, Inc. |
Antibody-evading virus vectors
|
|
CA3096293A1
(en)
|
2018-04-27 |
2019-10-31 |
Rocket Pharmaceuticals, Ltd. |
Gene therapy for cns degeneration
|
|
AU2019270900B2
(en)
|
2018-05-15 |
2026-03-12 |
President And Fellows Of Harvard College |
Viral vectors exhibiting improved gene delivery properties
|
|
AU2019268330A1
(en)
|
2018-05-15 |
2020-11-26 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of Parkinson's disease
|
|
TW202015742A
(zh)
|
2018-05-15 |
2020-05-01 |
美商航海家醫療公司 |
投遞腺相關病毒（ａａｖ）之組成物和方法
|
|
WO2019222444A2
(en)
|
2018-05-16 |
2019-11-21 |
Voyager Therapeutics, Inc. |
Directed evolution
|
|
CN112204145B
(zh)
*
|
2018-06-01 |
2024-03-26 |
佛罗里达大学研究基金会有限公司 |
用于治疗显性视网膜色素变性的组合物和方法
|
|
US12163129B2
(en)
|
2018-06-08 |
2024-12-10 |
University Of Massachusetts |
Antisense oligonucleotides to restore dysferlin protein expression in dysferlinopathy patient cells
|
|
MX2021001395A
(es)
|
2018-08-03 |
2021-08-11 |
Genzyme Corp |
Arni variante contra alfa-sinucleína.
|
|
CN109022487A
(zh)
*
|
2018-08-15 |
2018-12-18 |
上海市第人民医院 |
一种表达p65的基因载体及其用于治疗视网膜神经节细胞变性的基因治疗药物
|
|
CN113966399A
(zh)
|
2018-09-26 |
2022-01-21 |
加州理工学院 |
用于靶向基因疗法的腺相关病毒组合物
|
|
EP3856762A1
(en)
|
2018-09-28 |
2021-08-04 |
Voyager Therapeutics, Inc. |
Frataxin expression constructs having engineered promoters and methods of use thereof
|
|
WO2020077091A1
(en)
*
|
2018-10-10 |
2020-04-16 |
Wisconsin Alumni Research Foundation |
Kir 7.1 gene therapy vectors and methods of using the same
|
|
EP4461814A3
(en)
*
|
2018-10-12 |
2025-02-26 |
Genzyme Corporation |
Generation of improved human pah for treatment of severe pku by liver-directed gene replacement therapy
|
|
WO2020077165A1
(en)
|
2018-10-12 |
2020-04-16 |
Voyager Therapeutics, Inc. |
Compositions and methods for delivery of aav
|
|
UY38407A
(es)
|
2018-10-15 |
2020-05-29 |
Novartis Ag |
Anticuerpos estabilizadores de trem2
|
|
US20230061069A1
(en)
*
|
2018-11-13 |
2023-03-02 |
Jayandharan Giridhara Rao |
A process for producing a plurality of sumoylation target-site modified aav vector and product thereof
|
|
US20210386870A1
(en)
*
|
2018-11-26 |
2021-12-16 |
Universitat Autònoma De Barcelona |
Fibroblast growth factor 21 (FGF21) gene therapy
|
|
SG11202105276TA
(en)
|
2018-12-03 |
2021-06-29 |
Univ Texas |
Oligo-benzamide analogs and their use in cancer treatment
|
|
WO2020140007A1
(en)
*
|
2018-12-28 |
2020-07-02 |
University Of Rochester |
Gene therapy for best1 dominant mutations
|
|
PL3906066T3
(pl)
*
|
2019-01-04 |
2024-09-02 |
Ultragenyx Pharmaceutical Inc. |
Konstrukty do terapii genowej do leczenia choroby wilsona
|
|
EP3911410A1
(en)
|
2019-01-18 |
2021-11-24 |
Voyager Therapeutics, Inc. |
Methods and systems for producing aav particles
|
|
WO2020154535A1
(en)
*
|
2019-01-23 |
2020-07-30 |
University Of Florida Research Foundation, Incorporated |
Highly efficient transduction and lateral spread in the retina by a novel aav virus enhanced by rational design
|
|
KR20210121132A
(ko)
|
2019-01-28 |
2021-10-07 |
코바, 인크. |
치료용 펩티드
|
|
SG11202108502UA
(en)
|
2019-02-04 |
2021-09-29 |
Freeline Therapeutics Ltd |
Polynucleotides
|
|
EP3935078A4
(en)
*
|
2019-03-04 |
2022-12-21 |
Duke University |
COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF RETINOPATHIES
|
|
AU2020231505A1
(en)
*
|
2019-03-04 |
2021-08-19 |
Adverum Biotechnologies, Inc. |
Sequential intravitreal administration of AAV gene therapy to contralateral eyes
|
|
US20220175961A1
(en)
*
|
2019-03-08 |
2022-06-09 |
Universite Paris-Saclay |
Improved therapeutic method for rare ocular diseases by gene replacement
|
|
JP7698583B2
(ja)
|
2019-03-21 |
2025-06-25 |
ギンコ バイオワークス インコーポレイテッド |
組換えアデノ随伴ウイルスベクター
|
|
MX2021012184A
(es)
*
|
2019-04-10 |
2022-01-24 |
Prevail Therapeutics Inc |
Terapias genicas para trastornos lisosomales.
|
|
EP3966227A1
(en)
|
2019-05-07 |
2022-03-16 |
Voyager Therapeutics, Inc. |
Compositions and methods for the vectored augmentation of protein destruction, expression and/or regulation
|
|
US12491263B2
(en)
|
2019-05-13 |
2025-12-09 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Polymer-based implant for retinal therapy and methods of making and using the same
|
|
JP7707081B2
(ja)
*
|
2019-05-17 |
2025-07-14 |
リサーチ インスティチュート アット ネイションワイド チルドレンズ ホスピタル |
網膜細胞を標的とした最適化された遺伝子治療
|
|
CA3142932A1
(en)
*
|
2019-06-10 |
2020-12-17 |
Homology Medicines, Inc. |
Adeno-associated virus compositions for arsa gene transfer and methods of use thereof
|
|
MX2021016014A
(es)
*
|
2019-06-27 |
2022-04-06 |
Univ Florida |
Mejora de la transducción mediada por aav en los tejidos oculares con ácido hialurónico.
|
|
US11446084B2
(en)
|
2019-07-12 |
2022-09-20 |
Neuralink Corp. |
Laser drilling of pia mater
|
|
EP3999119B1
(en)
*
|
2019-07-15 |
2024-09-11 |
Meiragtx UK II Limited |
Modified aav capsid proteins for treatment of arthritic disease
|
|
CN110295151A
(zh)
*
|
2019-07-17 |
2019-10-01 |
博鑫仪器(天津)有限公司 |
一类腺依赖病毒病毒重组质粒、重组病毒及构建方法
|
|
US20220281930A1
(en)
*
|
2019-08-23 |
2022-09-08 |
Duke University |
Compositions and methods for the treatment of pathological pain and itch
|
|
US20220324921A1
(en)
*
|
2019-09-03 |
2022-10-13 |
University Of Cincinnati |
Methods and compositions for the treatment of als
|
|
US20220333133A1
(en)
|
2019-09-03 |
2022-10-20 |
Voyager Therapeutics, Inc. |
Vectorized editing of nucleic acids to correct overt mutations
|
|
EP4041755A4
(en)
*
|
2019-10-10 |
2023-10-25 |
Solid Biosciences Inc. |
Modified aav capsids and uses thereof
|
|
IL292297A
(en)
*
|
2019-10-17 |
2022-06-01 |
Stridebio Inc |
Adeno-associated viral vectors for treatment of niemann-pick disease type c
|
|
US20220389457A1
(en)
*
|
2019-10-23 |
2022-12-08 |
The Trustees Of The University Of Pennsylvania |
Compositions for drg-specific reduction of transgene expression
|
|
WO2021092300A1
(en)
*
|
2019-11-08 |
2021-05-14 |
President And Fellows Of Harvard College |
Viral capsid polypeptides
|
|
CN113025618B
(zh)
*
|
2019-12-24 |
2024-02-06 |
朗信启昇(苏州)生物制药有限公司 |
一种x连锁遗传性视网膜劈裂症的基因治疗方案与应用
|
|
BR112022014852A2
(pt)
|
2020-01-29 |
2022-10-11 |
Genzyme Corp |
Proteínas modificadas do capsídeo viral adenoassociado para terapia gênica ocular e métodos de uso das mesmas
|
|
CN115485024A
(zh)
*
|
2020-02-07 |
2022-12-16 |
纽约市哥伦比亚大学理事会 |
重编程代谢组以延迟发病或治疗神经变性
|
|
CN115210248A
(zh)
*
|
2020-02-18 |
2022-10-18 |
北卡罗来纳大学查佩尔希尔分校 |
Aav衣壳-启动子相互作用和细胞选择性基因表达
|
|
US12258566B2
(en)
*
|
2020-02-28 |
2025-03-25 |
University Of Massachusetts |
Oligonucleotides for PRNP modulation
|
|
JP2023517929A
(ja)
|
2020-03-11 |
2023-04-27 |
マサチューセッツ アイ アンド イヤー インファーマリー |
Ｎｍｎａｔ１関連網膜変性に対する遺伝子療法
|
|
TW202204377A
(zh)
*
|
2020-03-31 |
2022-02-01 |
麻州大學 |
蛋白殼變體及其用途
|
|
CA3174863A1
(en)
*
|
2020-04-14 |
2021-10-21 |
Ana BUJ BELLO |
Vectors for the treatment of acid ceramidase deficiency
|
|
EP4135841A1
(en)
|
2020-04-15 |
2023-02-22 |
Voyager Therapeutics, Inc. |
Tau binding compounds
|
|
IL298001A
(en)
|
2020-05-13 |
2023-01-01 |
Voyager Therapeutics Inc |
Redirecting tropism of adeno-associated virus capsids
|
|
WO2021247995A2
(en)
|
2020-06-04 |
2021-12-09 |
Voyager Therapeutics, Inc. |
Compositions and methods of treating neuropathic pain
|
|
EP4165193A4
(en)
*
|
2020-06-13 |
2024-07-24 |
Oculogenex Inc. |
AAV-MEDIATED GENE TRANSFER FOR RETINOPATHY
|
|
CN113952472A
(zh)
*
|
2020-07-21 |
2022-01-21 |
英斯培瑞有限公司 |
用于治疗眼部疾病的组合物和方法
|
|
WO2022017630A1
(en)
|
2020-07-23 |
2022-01-27 |
Ucl Business Ltd |
GENE THERAPY VECTOR FOR eEF1A2 AND USES THEREOF
|
|
US20230285596A1
(en)
|
2020-07-27 |
2023-09-14 |
Voyager Therapeutics, Inc |
Compositions and methods for the treatment of niemann-pick type c1 disease
|
|
WO2022026409A1
(en)
|
2020-07-27 |
2022-02-03 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of neurological disorders related to glucosylceramidase beta deficiency
|
|
JP2023536618A
(ja)
|
2020-08-05 |
2023-08-28 |
スペースクラフト セブン リミテッド ライアビリティ カンパニー |
Ｃｓｒｐ３（システイン及びグリシンリッチタンパク質３）遺伝子治療
|
|
CA3185267A1
(en)
|
2020-08-07 |
2022-02-10 |
Spacecraft Seven, Llc |
Plakophilin-2 (pkp2) gene therapy using aav vector
|
|
CA3189878A1
(en)
*
|
2020-08-19 |
2022-02-24 |
Colin O'BANION |
Adeno-associated virus vectors for treatment of rett syndrome
|
|
JP2023540756A
(ja)
*
|
2020-09-04 |
2023-09-26 |
オハイオ・ステイト・イノベーション・ファウンデーション |
向上した形質導入効率及び脳内における広範な分布を有する組換えアデノ随伴ウイルスベクターの新規の操作されたキャプシド血清型
|
|
US20230392166A1
(en)
*
|
2020-10-21 |
2023-12-07 |
Wisconsin Alumni Research Foundation |
Anti-apoptotic vector and method of using the same
|
|
US20220160825A1
(en)
*
|
2020-11-25 |
2022-05-26 |
The Penn State Research Foundation |
Brain repair after traumatic brain injury through neurod1-mediated astrocyte-to-neuron conversion
|
|
WO2022178410A1
(en)
*
|
2021-02-22 |
2022-08-25 |
The Regents Of The University Of Colorado, A Body Corporate |
Viral vector-based gene therapy for ocular conditions
|
|
CN115044614B
(zh)
*
|
2021-03-09 |
2023-10-20 |
上海目镜生物医药科技有限公司 |
一种用于基因靶向与表达的aav-8型血清型的改造型载体及其构建方法及应用
|
|
US20240218396A1
(en)
*
|
2021-04-26 |
2024-07-04 |
Grace Science, Llc |
Compositions and methods for treating ngyl1 deficiency
|
|
WO2022235566A1
(en)
*
|
2021-05-03 |
2022-11-10 |
North Carolina State University |
Compositions and methods related to the treatment of ocular diseases in equines
|
|
WO2023030541A1
(en)
*
|
2021-09-06 |
2023-03-09 |
Huigene Therapeutics Co., Ltd. |
Treatment of rpe65-associated eye diseases and disorders
|
|
EP4433490A2
(en)
|
2021-11-17 |
2024-09-25 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of neurological disorders related to glucosylceramidase beta deficiency
|
|
EP4442830A4
(en)
|
2021-11-29 |
2025-04-30 |
Shanghai Regenelead Therapies Co., Ltd. |
AADC/GDNF polynucleotide and use thereof in the treatment of Parkinson's disease
|
|
AU2023220237A1
(en)
|
2022-02-21 |
2024-08-15 |
Shanghai Regenelead Therapies Co., Ltd |
Vegf-binding molecule and pharmaceutical use thereof
|
|
US20250213727A1
(en)
*
|
2022-03-25 |
2025-07-03 |
Regenxbio Inc. |
Dominant-negative tumor necrosis factor alpha adeno-associated virus gene therapy
|
|
WO2023202637A1
(en)
*
|
2022-04-19 |
2023-10-26 |
Shanghai Vitalgen Biopharma Co., Ltd. |
Recombinant aav vectors for treating neurodegenerative disorders
|
|
EP4514949A1
(en)
|
2022-04-25 |
2025-03-05 |
Hadasit Medical Research Services&Development Ltd. |
Methods and compositions for treating vision loss
|
|
US20250171778A1
(en)
*
|
2022-04-25 |
2025-05-29 |
Myrtelle Inc. |
Treatments of Disorders of Myelin
|
|
CA3255627A1
(en)
|
2022-05-06 |
2023-11-09 |
Novartis Ag |
NEW VP2 FUSION POLYPEPTIDES OF RECOMBINANT AAV
|
|
WO2023240220A1
(en)
*
|
2022-06-09 |
2023-12-14 |
The University Of North Carolina At Chapel Hill |
Aav-sgsh vectors for treatment of mucopolysaccharidosis iiia
|
|
WO2023240236A1
(en)
|
2022-06-10 |
2023-12-14 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of spinal muscular atrophy related disorders
|
|
EP4551253A1
(en)
|
2022-07-08 |
2025-05-14 |
Ospedale San Raffaele S.r.l. |
Transgene cassettes
|
|
EP4303226A1
(en)
|
2022-07-08 |
2024-01-10 |
Ospedale San Raffaele S.r.l. |
Transgene cassettes and epigenetic silencers for the treatment of disorders
|
|
JP2025524636A
(ja)
*
|
2022-07-12 |
2025-07-30 |
リサーチ インスティチュート アット ネイションワイド チルドレンズ ホスピタル |
アデノ随伴ウイルス遺伝子療法産物及び方法
|
|
WO2024163012A1
(en)
|
2023-02-02 |
2024-08-08 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of neurological disorders related to glucosylceramidase beta deficiency
|
|
WO2024218311A1
(fr)
|
2023-04-21 |
2024-10-24 |
Pulsesight Therapeutics |
Compositions à base de décorine pour la réparation et la régéneration de l'épithélium pigmentaire de la rétine
|
|
GB202306952D0
(en)
*
|
2023-05-11 |
2023-06-28 |
Neurochase Innovations Ltd |
Method
|
|
WO2025128817A1
(en)
|
2023-12-15 |
2025-06-19 |
Genzyme Corporation |
Artificial micrornas targeting tau
|
|
TW202547561A
(zh)
|
2024-01-25 |
2025-12-16 |
美商健臻公司 |
基於ｆｕｓ向大腦遞送病毒顆粒之方法
|
|
TW202548014A
(zh)
|
2024-01-26 |
2025-12-16 |
美商健臻公司 |
靶向亨丁頓舞蹈症之人工ｍｉｃｒｏｒｎａ
|
|
WO2025160429A1
(en)
|
2024-01-26 |
2025-07-31 |
Genzyme Corporation |
Artificial micrornas targeting snca
|
|
CN120829932A
(zh)
*
|
2024-04-18 |
2025-10-24 |
临港国家实验室 |
治疗眼部疾病的药物组合物及方法
|